Acute Market Reports announces that it has published a new study Cardiac and Lung Surgical Robots Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021.  The 2015 study has 223 pages, 85 tables and figures.  Worldwide Cardiac and Lung surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and decrease the number of ports needed for minimally invasive surgery.

The automated process revolution in surgery and communications is being implemented via robots.  Robots automation of systems is providing significant improvement in the accuracy of surgery and the repeatability of process.

Intuitive Surgical owns the market as the major participant with compelling market share in cardiac and lung surgical robots.  This leadership position will need to be defended as other vendor products, now in clinical trials come to market.   Advanced technology, an installed base and a well trained core group of surgeons give Intuitive Surgical market advantage.

View Full Report:

Patients for some types of procedures fare better when the heart or lung surgery is done by surgical robots.  The documentation of improvements in care delivery, the ability to ensure better outcomes from surgery promise that cardiac and lung surgical robotics is a strong growth market.

Heart disease is still the largest disease worldwide.  The issue for cardiac and lung robotic surgery is that so many heart patients exist.

Every leading surgeon working to perform heart and lung robotic surgery has worked to be accepted to practice at a hospital that has those robotic devices.  The really talented surgeons depend on hospitals having the cardiac robotic equipment.    In order to attract physicians and patients, the hospitals have to purchase the surgical equipment.

Download Full Report With TOC:

The market penetration of the cardiac and lung surgical robots will go to 100 percent in the US top hospitals within five years.   As the surgeons migrate to the places that have the robotic surgical equipment, other hospitals and their potential patient populations notice.    If the hospital does not have the surgical robotic equipment, it will not have any surgeons, this is a bad situation for a hospital.  The cardiac and lung robotic surgical equipment permits better surgery and the surgeons and patients know this.

Cardiac and lung robotic surgery is poised to eclipse open surgery.  It is used in the categories of     lobectomy, thoracic revascularization, and mitral valve repair surgery.  Surgical robots are positioned to become the standard of care for hospitals in the delivery of some heart surgery.    The emerging group of several surgical robotic companies will collectively have enough marketing dollars and enough marketing clout to drive replacement of virtually all open cardiac and lung surgery.

Larger hospitals that can afford the expenditure are adopting heart and lung robotic surgical devices to improve their outcomes numbers.  Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly.   Hospital robotic systems have an emphasis on outcomes improvement during surgery.  This has resulted in investment in robotics technology that is useful, and achieves positive patient outcomes.

View all Reports of this Category @:

Technology is enhancing a wide variety of procedures in many cardiac surgical specialties.  Cardiac and thoracic surgeons at leading hospitals use robotic surgical systems increasingly.  The aim is to perform more of the one-hundred thousand MIS surgical procedures of various types using robots.  The surgeries performed by robot include cardiothoracic and vascular surgery.   These surgical applications are cleared by the FDA.

The technology uses metal tubes attached to the arms are inserted through the ports, and the cutting and visualization instruments are introduced through the tubes into the patient’s body.  The surgeon performs the procedure while sitting at a console, manipulating the instrument controls and viewing the operation through a vision system.  When a surgeon needs to change an instrument the instrument is withdrawn from the surgical field using the controls at the console and the nursing assistants switch instruments as per the physician instruction.  This is done many times during an operation.

The cardiac and lung surgical robot market is characterized enormous variety and innovation.  A surgical robot recurring revenue business model is essentially a large one time purchase for a system complimented by replaceable or disposable instruments that cumulatively make the market a much larger and sustainable ongoing market.   Vendors make money from the one time sale of a system and recurring revenue from sale of devices used in every operation.

Initially, a vendor sells and installs the surgical system into new customer accounts.  Once systems are sold into customer accounts, the vendor generates recurring revenue as customers use the system to perform surgery.  To do cardiac and lung robotic surgeries, the customers need to buy and consume instruments and accessory products.   Vendors also generate recurring revenue from system service.


About Us:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Our database consists of 200,000+ market research reports with detailed & minute market research.

Acute Market Reports

Office No 101, 1st Floor,

Aditi Mall, Baner,

Pune, MH, 411045


Toll Free(US/CANADA): +1-855-455-8662



Website: Acute Market Reports